Back to top
more

Gilead Sciences, Inc. (GILD)

(Delayed Data from NSDQ)

$65.23 USD

65.23
4,505,747

-0.12 (-0.18%)

Updated Oct 17, 2019 04:00 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.50%
17.69%
9.28%
4.86%
1.63%
10.50%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

A Value | C Growth | A Momentum | A VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for GILD

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Gilead Sciences, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Assets          
Cash & Equivalents 30,089 25,510 11,895 14,607 10,128
Receivables 3,327 3,851 4,514 5,854 4,635
Notes Receivable 0 0 0 0 0
Inventories 814 801 1,587 1,955 1,386
Other Current Assets 1,606 1,661 2,449 2,347 1,565
Total Current Assets 35,836 31,823 20,445 24,763 17,714
Net Property & Equipment 4,006 3,295 2,865 2,276 1,674
Investments & Advances 1,423 11,184 20,485 11,601 1,598
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 402 324 236
Intangibles 19,855 21,259 10,143 11,419 12,245
Deposits & Other Assets 2,555 2,722 2,637 1,456 1,197
Total Assets 63,675 70,283 56,977 51,839 34,664
Liabilities & Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Notes Payable 0 0 0 0 0
Accounts Payable 790 814 1,206 1,178 955
Current Portion Long-Term Debt 2,748 2,747 0 983 483
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 7,067 8,074 7,811 7,290 4,084
Income Taxes Payable 0 0 0 0 105
Other Current Liabilities 0 0 202 440 134
Total Current Liabilities 10,605 11,635 9,219 9,891 5,761
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 51
Convertible Debt 0 0 0 2 15
Long-Term Debt 25,614 31,353 26,642 21,590 11,921
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 5,922 6,794 1,753 1,243 1,097
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 42,141 49,782 37,614 32,726 18,845
Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 2
Capital Surplus 2,282 1,264 454 444 2,391
Retained Earnings 19,024 19,012 18,154 18,001 12,732
Other Equity 227 224 754 667 694
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 21,534 20,501 19,363 19,113 15,819
Total Liabilities & Shareholder's Equity 63,675 70,283 56,977 51,839 34,664
Total Common Equity 21,534 20,501 19,363 19,113 15,819
Shares Outstanding 1,293.60 1,306.20 1,317.40 1,441.10 1,508.60
Book Value Per Share 16.65 15.70 14.70 13.26 10.49

Fiscal Year End for Gilead Sciences, Inc. falls in the month of December.

All items in Millions except Per Share data.

9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Assets          
Cash & Equivalents NA 27,183 27,904 30,089 28,466
Receivables NA 3,396 3,283 3,327 3,465
Notes Receivable NA 0 0 0 0
Inventories NA 884 898 814 816
Other Current Assets NA 2,264 1,939 1,606 2,171
Total Current Assets NA 33,727 34,024 35,836 34,918
Net Property & Equipment NA 4,249 4,116 4,006 3,791
Investments & Advances NA 3,051 2,221 1,423 2,378
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 19,269 19,555 19,855 20,431
Deposits & Other Assets NA 2,914 2,921 2,555 2,787
Total Assets NA 63,210 62,837 63,675 64,305
Liabilities & Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Notes Payable NA 0 0 0 0
Accounts Payable NA 617 577 790 580
Current Portion Long-Term Debt NA 1,999 2,498 2,748 2,747
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 6,345 6,322 7,067 6,789
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 8,961 9,397 10,605 10,116
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 25,661 24,080 25,614 25,164
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 7,269 5,922 6,018
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 40,459 40,746 42,141 41,298
Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 2,684 2,494 2,282 2,118
Retained Earnings NA 19,829 19,326 19,024 20,706
Other Equity NA 237 270 227 182
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 22,751 22,091 21,534 23,007
Total Liabilities & Shareholder's Equity NA 63,210 62,837 63,675 64,305
Total Common Equity 0 22,751 22,091 21,534 23,007
Shares Outstanding 1,266.40 1,266.40 1,274.90 1,293.60 1,293.60
Book Value Per Share 0.00 17.97 17.33 16.65 17.79